NM_001303618.2:c.728-10104A>G
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001303618.2(CD226):c.728-10104A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.769 in 152,098 control chromosomes in the GnomAD database, including 46,586 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.77 ( 46586 hom., cov: 32)
Consequence
CD226
NM_001303618.2 intron
NM_001303618.2 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.897
Publications
6 publications found
Genes affected
CD226 (HGNC:16961): (CD226 molecule) This gene encodes a glycoprotein expressed on the surface of NK cells, platelets, monocytes and a subset of T cells. It is a member of the Ig-superfamily containing 2 Ig-like domains of the V-set. The protein mediates cellular adhesion of platelets and megakaryocytic cells to vascular endothelial cells. The protein also plays a role in megakaryocytic cell maturation. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2015]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.875 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.770 AC: 116987AN: 151984Hom.: 46586 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
116987
AN:
151984
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.769 AC: 117019AN: 152098Hom.: 46586 Cov.: 32 AF XY: 0.770 AC XY: 57263AN XY: 74366 show subpopulations
GnomAD4 genome
AF:
AC:
117019
AN:
152098
Hom.:
Cov.:
32
AF XY:
AC XY:
57263
AN XY:
74366
show subpopulations
African (AFR)
AF:
AC:
22620
AN:
41426
American (AMR)
AF:
AC:
11774
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
AC:
3031
AN:
3470
East Asian (EAS)
AF:
AC:
3894
AN:
5160
South Asian (SAS)
AF:
AC:
3802
AN:
4820
European-Finnish (FIN)
AF:
AC:
9387
AN:
10608
Middle Eastern (MID)
AF:
AC:
234
AN:
294
European-Non Finnish (NFE)
AF:
AC:
59907
AN:
68012
Other (OTH)
AF:
AC:
1674
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1233
2466
3700
4933
6166
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
848
1696
2544
3392
4240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2668
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.